SB256
Passed Senate, In House(New Title) establishing safety and care requirements for clinician-administered drugs.
Status
Hearing
- Date
- April 07, 2026
- Time
- 2:15 PM
- Committee
- House Commerce and Consumer Affairs
- Location
- GP Room 159
Testimony
1 total submissions
Bill Docket
Public Hearing: 04/07/2026 02:15 pm GP 159
HouseApril 02, 2026
Subcommittee Work Session: 04/08/2026 10:00 am GP 229
HouseApril 01, 2026
Vacated and Referred to Commerce and Consumer Affairs (Rep. Kofalt): MA VV (in recess of) 02/19/2026 HJ 5
HouseMarch 02, 2026
Introduced (in recess of) 02/19/2026 and referred to Health, Human Services and Elderly Affairs HJ 5
HouseFebruary 26, 2026
Ought to Pass with Amendment #2025-3029s, MA, VV; OT3rdg; 01/07/2026; SJ 1
SenateJanuary 07, 2026
Committee Amendment # 2025-3029s, AA, VV; 01/07/2026; SJ 1
SenateJanuary 07, 2026
Committee Report: Ought to Pass with Amendment # 2025-3029s, 01/07/2026; Vote 5-0; CC; SC 46
SenateOctober 22, 2025
Rereferred to Committee, MA, VV; 03/06/2025; SJ 6
SenateMarch 06, 2025
Committee Report: Rereferred to Committee, 03/06/2025; Vote 5-0; CC; SC 11
SenateFebruary 21, 2025
Hearing: 02/12/2025, Room 101, LOB, 09:15 am; SC 9
SenateFebruary 05, 2025
Introduced 01/09/2025 and Referred to Health and Human Services; SJ 3
SenateJanuary 23, 2025